CoChat

Bile Acid Synthesis: From Nature to the Chemical Modification and Synthesis and Their Applications as Drugs and Nutrients

Open access
Šarenac, Tanja M., Mikov, Momir · 2018 · Frontiers in Pharmacology
Cited by 156

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Bile acids are amphiphilic molecules with 24 carbon atoms, consisting of a hydrophobic and a rigid steroid nucleus, which they are attached a hydrophilic hydroxyl groups and a flexible acidic aliphatic side chain . The steroidal core of bile acids constitutes a saturated cyclopentanoperhydrophenanthrene skeleton, consisting of three six-membered (A, B and C) and one five-membered ring (D). Primary bile acids are produced in the hepatocytes, while secondary bile acids are formed by modifying of primary bile acids in the intestinal lumen, i.e. by the reactions of 7alfa−dehydroxylation and deconjugation of cholic and chenodeoxycholic acid. The most important secondary bile acids are deoxycholic and lithocholic acid. Their effects, bile acids realize through nuclear FXR receptors and membrane TGR5 receptors. It has been found that bile acids are also associated with other receptor-vitamin D receptor (VDR), which the most significant ligand is calcitriol, as well as for the pregnane X receptor (PXR) and potentially for the constitutive androstane receptor (CAR), whose ligands are numerous, structurally different xenobiotics, which are associated with greater affinity for bile acids. Bile acids as absorption promoters have the potential to aid intestinal, buccal, transdermal, ocular, nasal, rectal and pulmonary absorption. Bile acids as therapeutic agents (drugs) have the potential to produce beneficial effects in sexually transmitted diseases, primary biliary cirrhosis, primary sclerosing cholangitis, gallstones, digestive tract diseases, cystic fibrosis and cancer. Ursodeoxycholic acid possesses cholesthetic and antiprotective properties and it is used in the treatment of hepatobiliary symptoms of cystic fibrosis. The ursodeoxocholic acid normalizes the function of the liver, tests and prevents the progression of fibrosis. Bile acids achieve most of their effects by modulating gene expression through nuclear receptors, as a transcription factor. In this paper, the different pathways of bile acid biosynthesis are explained as well as chemical modifications and synthesis of different keto derivatives of bile acids. Also, the effects of bile acids in digestion as nutrients, their role as drugs, and in particular the emphasis on the hypoglycemic properties of 7alfa, 12alfa−dihydroxy−12−keto−5beta−cholanic acid in the treatment of diabetes mellitus were examined in detail.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2018.00939

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 156

Metadata

Authors
Šarenac, T. M., & Mikov, M.
Venue
Frontiers in Pharmacology
Published
2018-09-25
Volume
9
Pages
939-939
ISSN
1663-9812 (ISSN-L)
OpenAlex
W2894156089
Cited by
156
References
8
FWCI
3.96
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.